Advocacy & Awareness

Advocacy Events & Calls to Action

Voice of the Patient Report

On May 1, 2024, the beginning of PWS Awareness Month, we announced the release of the Voice of the Patient Report. This timely filing marks a significant moment for the Prader-Willi syndrome community! The report gives crucial insights that amplify the perspective of individuals and families affected by PWS and sheds light on aspects of PWS that may not be fully captured in drug trials alone. Integrating the patient’s voice throughout the drug approval process for PWS treatments is essential for the U.S. Food and Drug Administration’s (FDA) comprehensive understanding and impactful decision-making. 

The Voice of the Patient Report was created following the June 2023 PWS Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting and is compiled of testimonials shared during the EL-PFDD meeting, as well as those submitted virtually.

PWSA | USA, FPWR, and IPWSO extend heartfelt gratitude to the entire PWS community for contributing to the success of this project. To truly amplify the patient’s voice, our entire community must commit to ongoing advocacy efforts. This entails incorporating patient perspectives into all facets of processes and systems, ensuring genuine and enduring change. It’s not solely about isolated advocacy initiatives—it’s about steadfast dedication to embracing and elevating the voices of those directly affected by Prader-Willi syndrome.

You can read the Voice of the Patient Report by clicking the button below.

Find your Representative

PWS State Qualifier Campaign

We are excited to share that several new community members are in the beginning stages of having PWS added to their state’s list of developmental disabilities.

PWS State Qualifier Campaign Map

If you or someone you know is interested in leading the charge in your state, please email PWSA | USA at Advocacy@pwsausa.org.

Meet some of PWSA | USA’s advocates

PWSA | USA's Advocacy in Action Webinar

Check Out PWSA | USA'S
PWS Awareness Month Hub

A Big Step Forward
EL-PFDD Meeting

Your voice made a difference! PWS’s First Externally Led Patient-Focused Drug Development Meeting was a success. We have officially filed the Voice of the Patient Report, which is a document put together to include the stories shared during the meeting and submitted virtually. Click the button below to find the report and to learn more about the EL-PFDD.

VISIT OUR BLOG

Advocating for Rare Diseases: Year-End Highlights and Uncertain Next Steps

Advocating for Rare Diseases: Year-End Highlights and Uncertain Next Steps

Dorothea Lantz, PWSA | USA Community Engagement Director, and Elaine Towle, PWSA | USA volunteer advocate, recently represented the rare disease community in critical meetings on Capitol Hill with Sen. Shaheen, Sen. Hassan, Sen. Rubio, and Sen. Braun. These discussions emphasized advancing legislative priorities for 2025, including rare disease drug development, improving Medicaid access for […]

Empowering Change: Inclusive Advocacy in Action

Empowering Change: Inclusive Advocacy in Action

Advocating for individuals with Prader-Willi syndrome (PWS) means embracing every voice and every story. At PWSA | USA, we believe that expanding diversity efforts is essential to ensure every family feels seen, heard, supported, and receives their PWS diagnosis as early as possible. The Power of Inclusion For Dorothea Lantz, Director of Community Engagement at […]

PWSA | USA Advocates for PWS on Capitol Hill and NORD Breakthrough Summit

PWSA | USA Advocates for PWS on Capitol Hill and NORD Breakthrough Summit

In a powerful week of advocacy, Dorothea Lantz, Director of Community Engagement at PWSA | USA, represented Prader-Willi syndrome (PWS) on Capitol Hill and at the 2024 NORD Breakthrough Summit in Washington, D.C., from October 20–22. The Summit gathered leaders across the rare disease community, including patient advocates, healthcare providers, researchers, and policymakers, all united […]

Scroll to top